Skip to main content
Today · Plain-English health journalism — fact-checked, ad-free, and free for everyone. · Every claim cited to the evidence.
Supplements

Tart Cherry Juice: The Evidence on Sleep, DOMS, and the Hypertrophy Trade-Off

Montmorency tart cherry juice has real published evidence: 25 minutes more sleep at 240 mL twice daily, 25-50% DOMS reduction at 480 mL around eccentric exercise. But the anti-inflammatory effect that helps DOMS may also blunt long-term hypertrophy gains, like post-exercise cold plunging does.

Share: 𝕏 f in
The published evidence on Montmorency tart cherry for sleep (Howatson 2012) and DOMS (Bell 2014): real benefits at modest doses. Plus the hypertrophy

Educational journalism, not medical advice. Every claim here is checked against its cited sources by editor Tim Bunce — a health writer, not a physician. It isn’t specific to your situation: for health decisions, talk to your own clinician. How we work →

The 60-second version

Tart cherry juice (Montmorency variety specifically) is one of the more surprising evidence-supported recovery supplements. The published trial work consistently shows two effects: better sleep quality at modest doses (240-480 mL daily), and reduced DOMS and faster recovery after eccentric or high-volume exercise. The mechanism for sleep is partly endogenous melatonin content in cherries (low absolute amount but bioavailable) and partly anti-inflammatory pathway effects. The DOMS effect is mediated by polyphenols, particularly anthocyanins, that blunt the inflammatory cascade after exercise-induced muscle damage. The two important caveats: (1) the trials use Montmorency cherry, not sweet cherry — effect size is brand-and-variety-dependent, and (2) the anti-inflammatory effect that helps DOMS may also slightly blunt long-term resistance-training hypertrophy adaptations, like post-exercise cold plunging does.

The sleep evidence

Howatson and colleagues at Northumbria ran the most-cited tart-cherry-sleep trial. Participants drank 240 mL of Montmorency cherry juice concentrate twice daily for 7 days. The outcomes:

Follow-up trials have generally replicated these findings, though effect sizes vary by population. The effect appears largest in adults with mild sleep complaints — less measurable in already-good sleepers Losso 2018.

The DOMS evidence

Multiple controlled trials of tart cherry supplementation around eccentric exercise (the kind that produces severe muscle damage and soreness) show meaningful effects:

The trials use Montmorency cherry, typically 480 mL of standard juice or 1-2 oz of concentrate, taken daily for 4-7 days surrounding the exercise bout (2-3 days before through 2-3 days after).

“Tart cherry concentrate supplementation produces clinically meaningful reductions in delayed-onset muscle soreness and accelerates strength recovery after eccentric exercise. The effects are most pronounced for marathon, ultramarathon, and high-volume eccentric protocols.”

— Bell et al., Nutrients, 2014 view source

The hypertrophy caveat

Like post-exercise cold plunging, tart cherry’s anti-inflammatory action may blunt long-term resistance-training adaptations. The published trial evidence here is less extensive than for cold plunging but trending in the same direction: chronic tart cherry use immediately around resistance training appears to produce smaller hypertrophy gains than placebo at 6-12 weeks. The mechanism is the same — reduced inflammation = reduced satellite-cell signal = reduced adaptation McLeay 2017.

The practical implication mirrors cold plunging:

Practical dosing

Safety and side effects

Practical takeaways

Recovery beyond sore muscles: the endurance evidence

The DOMS research above mostly involves short, lab-controlled eccentric exercise. A separate question is whether tart cherry helps you bounce back from a long, real-world endurance effort, where the damage is less about a few hard eccentric reps and more about hours of cumulative mechanical and metabolic stress. The most-cited test of this is a randomized controlled trial in 20 recreational marathon runners who drank tart cherry juice or a placebo for five days before a marathon, on race day, and for 48 hours afterward Howatson 2010. Isometric muscle strength recovered significantly faster in the cherry group, and the markers of inflammation and oxidative stress that typically spike after a marathon were blunted: interleukin-6 and C-reactive protein (both signals the body uses to coordinate inflammation) were lower, total antioxidant status was roughly 10% higher, and lipid peroxidation (a measure of oxidative damage to cell membranes) was reduced at 48 hours Howatson 2010.

Notably, creatine kinase and lactate dehydrogenase, two enzymes that leak from damaged muscle, did not differ between groups in that study Howatson 2010. That detail matters: it suggests tart cherry did not prevent the muscle damage itself so much as dampen the downstream inflammatory and oxidative response to it, helping function return sooner. This fits the broader picture that the active compounds, the polyphenols and anthocyanins, work mainly by modulating inflammation and oxidative stress rather than by armoring the muscle fiber Bell 2014. The practical read for endurance athletes is the same logic as the hypertrophy caveat in reverse: when the goal is to recover and perform again soon (a race, a multi-day event, a tournament), faster recovery is the prize and the anti-inflammatory effect is welcome. When the goal is long-term adaptation from your hardest training blocks, blunting that same inflammatory signal day after day may not be what you want.

Tart cherry and gout: a popular claim that does not survive a rigorous test

Tart cherry is one of the most common home remedies people try for gout, a form of arthritis caused by needle-like uric-acid crystals forming in the joints. The interest is not baseless. In a controlled study, a single dose of Montmorency tart cherry concentrate lowered blood uric acid and C-reactive protein in healthy adults within hours, and the effect appeared to be independent of the specific anthocyanin metabolites measured in plasma, hinting at more than one active pathway Bell 2014b. Marathon runners in the recovery trial above also showed a small drop in uric acid Howatson 2010. Headlines and supplement marketing have leaned hard on findings like these.

But an acute dip in a healthy person's uric acid is a long way from preventing gout attacks in someone who actually has the disease, and the strongest test to date is sobering. A randomized, placebo-controlled trial gave 50 people with gout (half of them also taking the standard urate-lowering drug allopurinol) one of four doses of tart cherry concentrate or placebo twice daily for 28 days, with repeated blood and urine sampling. There was no significant effect of any cherry dose on serum urate or on urinary urate excretion. The authors concluded plainly that "tart cherry concentrate had no effect" on uric acid, and that if cherries do anything for gout flares over longer periods, it is "not likely to be mediated by reduction" in uric acid Stamp 2020. In other words, the mechanism most people assume, that cherries lower uric acid the way a gout drug does, is not supported when it is tested properly in patients.

The honest summary is that tart cherry is not a treatment for gout. It will not replace allopurinol, febuxostat, or the lifestyle and dietary management your clinician recommends. Anyone with gout, kidney disease, or recurrent flares should manage the condition with their doctor rather than self-treating with juice, and should be skeptical of products marketed as "natural" gout cures. If you enjoy tart cherry and tolerate the sugar load, there is no evidence it is harmful in moderate amounts, but treat any benefit as unproven.

Blood pressure and heart health: promising press, underwhelming trials

You will find widely circulated claims that tart cherry juice lowers blood pressure and "bad" LDL cholesterol, often traced to a small study in adults aged 65 to 80 that reported a roughly 4 mmHg drop in systolic blood pressure. That kind of result is biologically plausible, since tart cherries supply potassium and polyphenols that other foods have linked to vascular benefits. But a single small study is a weak foundation, and the best-designed follow-up did not reproduce it. A three-month randomized, placebo-controlled trial in 50 middle-aged adults found that Montmorency cherry concentrate had no significant effect on systolic or diastolic blood pressure, on total, LDL, or HDL cholesterol or triglycerides, on fasting insulin, glucose, or insulin resistance, on hs-CRP, or on measures of blood-vessel function and arterial stiffness Kimble 2021. The authors' conclusion was that the concentrate "has no influence on cardiometabolic indices in middle-aged adults" Kimble 2021.

The takeaway for readers is one of calibration, not dismissal. The early positive signal in older adults may reflect that people who already have elevated blood pressure have more room to improve, whereas healthier middle-aged adults do not. But as it stands, the cardiovascular case for tart cherry is unproven and the evidence is conflicting. Do not substitute cherry juice for prescribed blood-pressure medication or for the diet, exercise, and weight management that have strong evidence behind them. If you have hypertension or high cholesterol, those are conversations to have with your clinician.

Does it help the aging brain? Read the funding line first

A growing set of studies asks whether the polyphenols in tart cherry can support cognition as we age, the same anti-inflammatory and antioxidant logic applied to the brain. In a 12-week randomized controlled trial, 37 cognitively healthy adults aged 65 to 80 who drank about 480 mL of Montmorency tart cherry juice daily showed improvements versus placebo on tasks of memory and reduced errors on an episodic visual-memory test, alongside small within-group gains in sustained attention and spatial working memory Chai 2019. On its face that is encouraging for anyone worried about age-related memory changes.

Two cautions keep this in perspective, and they are the kind of thing worth teaching readers to look for. First, the trial was small and short, the participants started with normal cognition, and several of the reported gains were within-group changes rather than clear advantages over placebo, so the findings are preliminary rather than definitive. Second, and importantly for an honest reading, the study was funded by the Cherry Marketing Institute's research committee, which also supplied the cherry concentrate Chai 2019. Industry funding does not automatically invalidate a result, and the authors declared no personal conflicts, but research on health claims funded by the food being studied tends, on average, to report more favorable outcomes, which is exactly why disclosing it matters. Much of the tart cherry literature, including some of the recovery and uric-acid work, has had cherry-industry support, so the prudent stance is to weight independent replications most heavily and treat single industry-funded studies as a reason for interest, not a reason for confidence. There is currently no good evidence that tart cherry prevents dementia or treats any cognitive disorder; if memory changes concern you, that is a matter for a clinician, not a juice aisle.

Who benefits and who probably doesn’t

Tart cherry is most relevant for:

Tart cherry is less relevant for:

Cost, quality, and selection

Cost considerations: a typical 480 mL/day protocol with brand-name tart cherry juice runs $4–7 per day. Concentrate is more cost-effective per dose (~$1–3 per day at typical concentrations). Capsules vary widely; check polyphenol content per serving for fair comparison.

Quality considerations:

References

Howatson 2012Howatson G, Bell PG, Tallent J, Middleton B, McHugh MP, Ellis J. Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality. Eur J Nutr. 2012;51(8):909-916. View source →
Losso 2018Losso JN, Finley JW, Karki N, et al. Pilot study of the tart cherry juice for the treatment of insomnia and investigation of mechanisms. Am J Ther. 2018;25(2):e194-e201. View source →
Bell 2014Bell PG, McHugh MP, Stevenson E, Howatson G. The role of cherries in exercise and health. Scand J Med Sci Sports. 2014;24(3):477-490. View source →
McLeay 2017McLeay Y, Stannard SR, Houltham S, Starck C. Dietary thiols in exercise: oxidative stress defence, exercise performance, and adaptation. J Int Soc Sports Nutr. 2017;14:12. View source →
Howatson 2010Howatson G, McHugh MP, Hill JA, et al. "Influence of tart cherry juice on indices of recovery following marathon running." Scandinavian Journal of Medicine & Science in Sports. 2010;20(6):843-852. PMID: 19883392. doi:10.1111/j.1600-0838.2009.01005.x View source →
Bell 2014bBell PG, Gaze DC, Davison GW, et al. "Montmorency tart cherry (Prunus cerasus L.) concentrate lowers uric acid, independent of plasma cyanidin-3-O-glucosiderutinoside." Journal of Functional Foods. 2014;11:82-90. doi:10.1016/j.jff.2014.09.004 View source →
Stamp 2020Stamp LK, Chapman P, Frampton C, et al. "Lack of effect of tart cherry concentrate dose on serum urate in people with gout." Rheumatology (Oxford). 2020;59(9):2374-2380. PMID: 31891407. doi:10.1093/rheumatology/kez606 View source →
Kimble 2021Kimble R, Keane KM, Lodge JK, Howatson G. "The Influence of Tart Cherry (Prunus cerasus, cv Montmorency) Concentrate Supplementation for 3 Months on Cardiometabolic Risk Factors in Middle-Aged Adults: A Randomised, Placebo-Controlled Trial." Nutrients. 2021;13(5):1417. PMID: 33922493. doi:10.3390/nu13051417 View source →
Chai 2019Chai SC, Jerusik J, Davis K, Wright RS, Zhang Z. "Effect of Montmorency tart cherry juice on cognitive performance in older adults: a randomized controlled trial." Food & Function. 2019;10(7):4423-4431. doi:10.1039/C9FO00913B View source →

Related reading